Abstract
Introduction: HCC accounts for approximately 75% of primary liver cancers and is the fourth leading cause of death from malignancy worldwide.Liver transplant (LT) is a curative treatment in some patients. The post-transplant recurrence rate of HCC is very wide, between 5 and 30%, due also to different listing policies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
